A thorough US-Canada submission readiness review covers dossier strategy, evidence, labeling, FDA/Health Canada compliance, gap assessments, ISO 13485 QMS, GMP readiness, and pre-submission meetings to prevent delays.
Verify your regulatory pathway early to avoid costly delays in US and Canadian markets. Conduct due diligence, understand FDA/Health Canada classifications, design a tailored approval strategy, perform gap analysis, and…
Verify your regulatory pathway early to avoid delays in US FDA or Health Canada approvals. Define use, map jurisdiction, classify products, and engage regulators for smooth market entry.
Guide outlines US and Canada regulatory pathways for new products, emphasizing correct classification (device class, cosmetic vs drug, combination), FDA and Health Canada submissions, and benefits of expert consultancy for…
Post-approval compliance in the US and Canada requires a risk-based plan covering surveillance, labeling, change control, license maintenance, supplier oversight, training, and audit readiness to sustain market access.
Reduce regulatory rework in pharma, cosmetics, and medical device submissions by performing gap analyses, adhering to FDA and Health Canada guidelines, mastering eCTD publishing, and ensuring MoCRA compliance for faster…
Call Now Button